<p>(A–I) Indicated groups of mice were infected i.t. with PR8 influenza virus (50 pfu unless otherwise specified). Loss of body weight (A) and temperature (B) was monitored. (C) Survival after infection with 100 pfu PR8. Values indicate mean ± SEM of 8–10 mice per group. (D) Virus titers in the lung at days 6 and 10 p.i. were measured by plaque-assay. (E–H) Comparison of immune responses in <i>Csf2</i><sup>−/−</sup>, <i>Batf3</i><sup>−/−</sup> and WT mice at day 10 post infection. (E) Percentages (upper panel) and total numbers (lower panel) of influenza NP34-specific CD8<sup>+</sup> T cells in the BAL, lung and lung-draining LN. (F) Virus-specific IFNγ and TNFα production in CD8<sup>+</sup> T cells of the BAL, lung and LN was analyzed by r...
<p><b>A)</b> Schematic of WT and <i>Tnf-/-</i> mouse i.n. infection with 1 x 10<sup>4</sup> PFU IAV ...
<p><b>A:</b> Mice were infected with 300,000 EID<sub>50</sub> of X-31 (H3N2) influenza and then were...
<p>10<sup>4</sup> purified CD8 T cells from CD45.1<sup>+</sup> WT or CD45.1<sup>+</sup> NOD2<sup>−/−...
<p>WT and β6 KO mice were infected with influenza as described in <a href="http://www.plospathogens....
<p>(<b>A</b>) Percentage of body weight loss after influenza infection. A weight loss of <20% and re...
<p>(<b>A–E</b>) BALB/c mice were infected with PR8 (0.1LD<sub>50</sub>) i.n. (<b>A</b>) Absolute num...
<p>(<b>A</b>) Survival, (<b>B</b>) viral burdens, and (<b>C</b>) albumin levels (5–7 mice/group) at ...
<p>B6 mice (5 mice/group) were infected with 10<sup>5</sup> (closed triangle) or 10<sup>2</sup> (ope...
<p>Mice were infected with 10<sup>5</sup> PFU of BJx109, HKx31 or PR8. (A) Weight loss. Mice were we...
<p>(<b>A</b>) Airway viral burdens (5–6 mice/group), (<b>B</b>) T cell numbers at 7 dpi (4–5 mice/gr...
<p>(A–F) Virus-specific ASC frequencies. DR1 (A–C) and B10 (D–F) mice were infected intranasally wit...
<p>WT and <i>Csf2</i><sup>−/−</sup> mice were infected i.t. with 50 pfu PR8 influenza virus. (A) Pan...
<p>A) C57BL/6 mice were primed with either X31-GP33 i.n. or LCMV Armstrong i.n. These mice, as well ...
<p>(A) Groups of 5 B6 mice were treated with purified anti-Ly6G (1A8) or rat IgG (IgG) antibodies 24...
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> PFU or 1×10<sup>8</...
<p><b>A)</b> Schematic of WT and <i>Tnf-/-</i> mouse i.n. infection with 1 x 10<sup>4</sup> PFU IAV ...
<p><b>A:</b> Mice were infected with 300,000 EID<sub>50</sub> of X-31 (H3N2) influenza and then were...
<p>10<sup>4</sup> purified CD8 T cells from CD45.1<sup>+</sup> WT or CD45.1<sup>+</sup> NOD2<sup>−/−...
<p>WT and β6 KO mice were infected with influenza as described in <a href="http://www.plospathogens....
<p>(<b>A</b>) Percentage of body weight loss after influenza infection. A weight loss of <20% and re...
<p>(<b>A–E</b>) BALB/c mice were infected with PR8 (0.1LD<sub>50</sub>) i.n. (<b>A</b>) Absolute num...
<p>(<b>A</b>) Survival, (<b>B</b>) viral burdens, and (<b>C</b>) albumin levels (5–7 mice/group) at ...
<p>B6 mice (5 mice/group) were infected with 10<sup>5</sup> (closed triangle) or 10<sup>2</sup> (ope...
<p>Mice were infected with 10<sup>5</sup> PFU of BJx109, HKx31 or PR8. (A) Weight loss. Mice were we...
<p>(<b>A</b>) Airway viral burdens (5–6 mice/group), (<b>B</b>) T cell numbers at 7 dpi (4–5 mice/gr...
<p>(A–F) Virus-specific ASC frequencies. DR1 (A–C) and B10 (D–F) mice were infected intranasally wit...
<p>WT and <i>Csf2</i><sup>−/−</sup> mice were infected i.t. with 50 pfu PR8 influenza virus. (A) Pan...
<p>A) C57BL/6 mice were primed with either X31-GP33 i.n. or LCMV Armstrong i.n. These mice, as well ...
<p>(A) Groups of 5 B6 mice were treated with purified anti-Ly6G (1A8) or rat IgG (IgG) antibodies 24...
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> PFU or 1×10<sup>8</...
<p><b>A)</b> Schematic of WT and <i>Tnf-/-</i> mouse i.n. infection with 1 x 10<sup>4</sup> PFU IAV ...
<p><b>A:</b> Mice were infected with 300,000 EID<sub>50</sub> of X-31 (H3N2) influenza and then were...
<p>10<sup>4</sup> purified CD8 T cells from CD45.1<sup>+</sup> WT or CD45.1<sup>+</sup> NOD2<sup>−/−...